Jeffrey W. Pollard

MRC Centre for Reproductive Health — United Kingdom

Immunology and Microbiology · Life Sciences

112h-index74.9kcitations436works11.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(149), Cancer Cells and Metastasis(61), Reproductive System and Pregnancy(61), Chemokine receptors and signaling(39), Cancer Immunotherapy and Biomarkers(33)

Publications435 total

Retraction Notice to: “CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure” Gastroenterology 2015;149:1896–1909.e14
Gastroenterology·2025
Abstract PR011: Efferocytic macrophage promotes pancreatic cancer liver metastasis
Cancer Research·2024
WCN24-1719 SUPPORT AND ADVOCACY FOR PAEDIATRIC NEPHROLOGY: THE IBADAN, NIGERIA – CALGARY, CANADA SISTER RENAL CENTRE (SRC) PROGRAM
Kidney International Reports·2024Open Access
Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis
Nature Cancer·2024· 3 citedOpen Access
Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis
Nature Cancer·2024· 66 citedOpen Access
Pleomorphic Lobular Carcinoma of the Male Breast: A Case Report and Review of Literature
Breast Global Journal·2024Open Access
Figure S4 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Figure S5 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Figure S2 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Data from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Figure S6 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Data from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Figure S5 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Figure S7 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Figure S6 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Figure S3 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Abstract 2751: ENIGMACTM discovery platform enables gene to function target validation for macrophage therapy
Cancer Research·2023
Figure S7 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Figure S1 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
Figure S3 from Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF
2023Open Access
page 1 of 22Next →

Frequent Co-authors

Elaine Y. Lin(7), Bin‐Zhi Qian(5), E. Richard Stanley(5), Claire E. Lewis(4), Luca Cassetta(4), Jiufeng Li(3), Takanori Kitamura(3), John S. Condeelis(3), Yarong Wang(3), Liyin Zhu(3), Daniel Soong(3), Michele De Palma(3), Philipp E. Scherer(3), Roy Noy(2), Johanna A. Joyce(2), Bin-Zhi Qian(2), Hui Zhang(2), Robert G. Russell(2), Jeffrey Wyckoff(2), Jeffrey E. Segall(2)